id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-305130-vz72ldbo	Keil, Shawn D.	Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light‐based photochemical treatment	2020-05-14		.txt	text/plain	3462	120	43	Silver Spring, MD: OCOD, 2020 31 FDA: Guidance for industry -revised recommendations to reduce the risk of transfusion-transmitted malaria Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors Risk factors for retrovirus and hepatitis virus infections in accepted blood donors Development of a multisystem surveillance database for transfusion-transmitted infections among blood donors in the United States Use of convalescent plasma therapy in two covid-19 patients with acute respiratory distress syndrome in Korea Effectiveness of convalescent plasma therapy in severe COVID-19 patients Treatment of 5 critically ill patients with COVID-19 with convalescent plasma FDA: Recommendations for Investigational COVID-19 Convalescent Plasma. The Mirasol Pathogen Reduction Technology (PRT) System was created to provide an additional layer of safety to blood products by reducing the risk of transfusion transmission of both known and emerging pathogens.	cache/cord-305130-vz72ldbo.txt	txt/cord-305130-vz72ldbo.txt
